Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Janet Freeman‐Daily"'
Autor:
Kathryn F. Mileham, Caroline Schenkel, Suanna S. Bruinooge, Janet Freeman‐Daily, Upal Basu Roy, Amy Moore, Robert A. Smith, Elizabeth Garrett‐Mayer, Lauren Rosenthal, Edward B. Garon, Bruce E. Johnson, Raymond U. Osarogiagbon, Shadia Jalal, Shamsuddin Virani, Mary Weber Redman, Gerard A. Silvestri
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 530-538 (2022)
Abstract Background An ASCO taskforce comprised of representatives of oncology clinicians, the American Cancer Society National Lung Cancer Roundtable (NLCRT), LUNGevity, the GO2 Foundation for Lung Cancer, and the ROS1ders sought to: characterize U.
Externí odkaz:
https://doaj.org/article/77e04cdb969842218b3ff0a67980c00e
Autor:
Andrea, Anampa-Guzmán, Janet, Freeman-Daily, Michael, Fisch, Emil, Lou, Nathan A, Pennell, Corrie A, Painter, Dorinda, Sparacio, Mark A, Lewis, Maimah, Karmo, Patricia F, Anderson, Stephanie L, Graff
Publikováno v:
JCO Oncology Practice. 18:578-583
PURPOSE: Patients who have cancer have leveraged the Internet to gain a better understanding of their disease and connect across geographic boundaries with others facing the same challenges. Online cancer communities have developed into resources tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c456a29c247305bc02b4cb5916fe435f
https://doi.org/10.1200/op.21.00763
https://doi.org/10.1200/op.21.00763
Autor:
Kathryn F. Mileham, Caroline Schenkel, Suanna S. Bruinooge, Janet Freeman‐Daily, Upal Basu Roy, Amy Moore, Robert A. Smith, Elizabeth Garrett‐Mayer, Lauren Rosenthal, Edward B. Garon, Bruce E. Johnson, Raymond U. Osarogiagbon, Shadia Jalal, Shamsuddin Virani, Mary Weber Redman, Gerard A. Silvestri
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 530-538 (2022)
Cancer Medicine
Cancer Medicine
Background An ASCO taskforce comprised of representatives of oncology clinicians, the American Cancer Society National Lung Cancer Roundtable (NLCRT), LUNGevity, the GO2 Foundation for Lung Cancer, and the ROS1ders sought to: characterize U.S. oncolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a743d8eed47c3c35fb21a4af673b0c7f
https://doi.org/10.1002/cam4.4459
https://doi.org/10.1002/cam4.4459
Autor:
Divya Ahuja Parikh, Bonnie J. Addario, Janet Freeman-Daily, Manali I. Patel, Guneet Walia, Lisa Goldman, Merel Hennink, Tori Tomalia, Lysa Buonanno
Publikováno v:
JCO Oncol Pract
PURPOSE: The discovery of driver oncogenes, such as ROS1, has led to the development of targeted therapies. Despite clinical advancements, gaps remain in our understanding of characteristics of patients with ROS1-positive ( ROS1+) cancers. The purpos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa212a1ab688e62061210b08abc32e39
https://doi.org/10.1200/jop.19.00135
https://doi.org/10.1200/jop.19.00135
Autor:
Kathryn Finch Mileham, Elizabeth Garrett-Mayer, Melinda Kaltenbaugh, Margaret Kelsey Kirkwood, Caroline Schenkel, Suanna Steeby Bruinooge, Raymond U. Osarogiagbon, Shadia Ibrahim Jalal, Amy Moore, Upal Kunal Basu Roy, Janet Freeman-Daily, Shamsuddin Virani, Edward B. Garon, Gerard A. Silvestri, Lauren Rosenthal, Robert A. Smith, Bruce E. Johnson
Publikováno v:
Journal of Clinical Oncology. 40:9127-9127
9127 Background: Guidelines have evolved from 2011-2019; there are now 23 approved therapies targeting various predictive biomarkers in mNSCLC. 2021 NCCN Guidelines advocate for a minimum of ALK, EGFR, BRAF, METex14, NTRK1/2/3, RET, KRAS, and ROS1 te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ff4efc32b0ec7ec71141ba3f599f33
https://doi.org/10.1200/jco.2022.40.16_suppl.9127
https://doi.org/10.1200/jco.2022.40.16_suppl.9127
Autor:
Maria E. Arcila, Umberto Malapelle, Giorgio V. Scagliotti, Christopher Abbosh, Lynette M. Sholl, Daniel Tan, Ignacio I. Wistuba, Christian Rolfo, Charles Swanton, Rafal Dziadziuszko, Charu Aggarwal, Rebecca Bunn, Heather A. Wakelee, Nir Peled, Maximilian Diehn, Fabrice Barlesi, M. Wynes, Trever G. Bivona, Philip C. Mack, Janet Freeman-Daily, Lecia V. Sequist, Caroline Dive, David R. Gandara, Natasha B. Leighl, Luis E. Raez, Tony Mok, Tetsuya Mitsudomi, Chandra P. Belani
Although precision medicine has had a mixed impact on the clinical management of patients with advanced-stage cancer overall, for NSCLC, and more specifically for lung adenocarcinoma, the advances have been dramatic, largely owing to the genomic comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d61f549e481b3b113e8e6c0f4fc957
http://hdl.handle.net/2318/1802181
http://hdl.handle.net/2318/1802181
Publikováno v:
American Society of Clinical Oncology Educational Book. :597-606
The art of practicing oncology has evolved substantially in the past 5 years. As more and more diagnostic tests, biomarker-directed therapies, and immunotherapies make their way to the oncology marketplace, oncologists will find it increasingly diffi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e966b25c7974b305d0174d4afb4d98
https://doi.org/10.1200/edbk_174794
https://doi.org/10.1200/edbk_174794
Publikováno v:
Nature Reviews Clinical Oncology. 17:65-66
As more patients with oncogene-driven non-small-cell lung cancer are treated with targeted therapies, they are joining forces online to form groups that provide support, education and advocacy focused on specific oncogenes. Herein, we discuss how the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4a5503df9b5219b2ac0b52452b9119
https://doi.org/10.1038/s41571-019-0314-1
https://doi.org/10.1038/s41571-019-0314-1
Autor:
Matthew S. Katz, Dee Sparacio, Colleen Young, David T. Cooke, Alicia C. Staley, Don S. Dizon, Charlie Blotner, Audun Utengen, Michael J. Fisch, Deanna J. Attai, Janet Freeman-Daily, Liz Salmi, Michael A. Thompson, Patricia F. Anderson
Publikováno v:
JCO clinical cancer informatics. 3
Twitter use has increased among patients with cancer, advocates, and oncology professionals. Hashtags, a form of metadata, can be used to share content, organize health information, and create virtual communities of interest. Cancer-specific hashtags
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0110ddcf83e742eec139ef34accaebd3
https://pubmed.ncbi.nlm.nih.gov/31251658
https://pubmed.ncbi.nlm.nih.gov/31251658
Autor:
Kim Norris, Janet Freeman-Daily, Upal Basu Roy, Becky Bunn, Cristina Chin, Jan Baranski, Amy Moore
Publikováno v:
Clinical Cancer Research. 26:PO-071
Background: The COVID-19 pandemic has presented an urgent and serious threat to multiple at-risk populations, including those with lung cancer (LC). This rapidly evolving crisis has seen a growing onslaught of information and guidance from multiple s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5de829516dfed29f7b593826e7f0f32e
https://doi.org/10.1158/1557-3265.covid-19-po-071
https://doi.org/10.1158/1557-3265.covid-19-po-071